[Achievements and prospects of the development of cardiology in Siberia]
Related Experiment Video
Updated: Aug 19, 2026
10:41
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
Published on: January 23, 2021
Kardiologiia
|October 1, 1985
Insights
Siberian cardiologists have advanced the study of arterial hypertension and coronary heart disease, focusing on regional challenges and future research in prevention and diagnostics.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Context:
- Focuses on the unique epidemiological landscape of Siberia and the Far East.
- Addresses the specific challenges of managing cardiovascular diseases in these regions.
- Highlights the achievements of regional medical professionals.
Purpose:
- To review and consolidate the accomplishments of Siberian cardiologists.
- To identify key research priorities for cardiovascular disease prevention and management.
- To discuss the development of novel population preventive check-up methods.
Summary:
- Details advancements in the epidemiology, diagnosis, treatment, and prophylaxis of arterial hypertension and coronary heart disease.
- Examines the specific environmental and social conditions influencing cardiovascular health in Siberia and the Far East.
- Discusses ongoing research into combined prevention strategies and innovative screening techniques.
Impact:
- Provides a comprehensive overview of regional cardiovascular research.
- Informs future research directions and public health strategies for Siberia.
- Aims to improve cardiovascular disease outcomes through enhanced prevention and diagnosis.
Abstract:
Achievements of Siberian cardiologists in the epidemiology, diagnosis, treatment and prophylaxis of arterial hypertension and coronary heart disease are described with reference to specific conditions of Siberia and the Far East. Research priorities, such as problems of combined prophylaxis and the development of new methods for preventive check-ups of the population in Siberia are discussed.
Related Concept Videos
01:27Development of the Heart
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...